Aberdeen Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-84,822
| Closed | -$15.6M | – | 1075 |
|
|
2021
Q2 | $15.6M | Sell |
84,822
-5,150
| -6% | -$946K | 0.03% | 401 |
|
|
2021
Q1 | $13.8M | Sell |
89,972
-1,907
| -2% | -$292K | 0.03% | 427 |
|
|
2020
Q4 | $14.4M | Sell |
91,879
-2,488
| -3% | -$389K | 0.04% | 379 |
|
|
2020
Q3 | $10.8M | Sell |
94,367
-16,539
| -15% | -$1.89M | 0.03% | 407 |
|
|
2020
Q2 | $12.4M | Sell |
110,906
-19,180
| -15% | -$2.15M | 0.03% | 368 |
|
|
2020
Q1 | $11.7M | Buy |
130,086
+13,632
| +12% | +$1.22M | 0.04% | 367 |
|
|
2019
Q4 | $12.6M | Buy |
116,454
+5,486
| +5% | +$593K | 0.03% | 415 |
|
|
2019
Q3 | $10.9M | Buy |
110,968
+11,311
| +11% | +$1.11M | 0.03% | 430 |
|
|
2019
Q2 | $13.1M | Buy |
99,657
+1,664
| +2% | +$218K | 0.03% | 445 |
|
|
2019
Q1 | $13.2M | Buy |
97,993
+30,026
| +44% | +$4.06M | 0.03% | 441 |
|
|
2018
Q4 | $6.67M | Sell |
67,967
-1,905
| -3% | -$187K | 0.02% | 522 |
|
|
2018
Q3 | $9.71M | Buy |
69,872
+6,873
| +11% | +$955K | 0.02% | 492 |
|
|
2018
Q2 | $7.82M | Buy |
62,999
+12,557
| +25% | +$1.56M | 0.02% | 520 |
|
|
2018
Q1 | $5.62M | Buy |
50,442
+1,401
| +3% | +$156K | 0.01% | 531 |
|
|
2017
Q4 | $5.87M | Buy |
49,041
+526
| +1% | +$62.9K | 0.01% | 531 |
|
|
2017
Q3 | $6.81M | Buy |
+48,515
| New | +$6.81M | 0.01% | 515 |
|